A review of multiple studies indicates that low-dose GLP-1 RAs can reduce pro-inflammatory markers such as TNF-alpha, IL-6, and hsCRP, contributing to improved quality of life and health outcomes in individuals with inflammatory conditions, including cardiovascular and kidney diseases
When administering semaglutide to research subjects, it is important to consider dose adjustments and take necessary precautions [5, 6]: Renal Dose Adjustments: No dosage adjustment is recommended for subjects with renal impairment
If you want to explore what weight loss options are available today, you can see if you qualify for Noom Med
Patients treated are those with type 2 diabetes
Sugar-sweetened foods and beverages can hinder weight loss while taking up valuable space in the diet for people with a limited appetite, Harris-Pincus says
Theoretical concerns include angiogenesis-related risk in patients with current or prior cancer, and effects on nitric oxide signaling that could matter for blood pressure